Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa in Heart Failure with Anemia
NCT00358215Phase 3Completed
- Sponsor
- Amgen
- Start
- Jun 2006
- Primary completion
- Oct 2012
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 36
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started Jun 2006; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00358215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358215.